



Markets
/
Stocks
/
nasdaq-sbfmw
/

Sunshine Biopharma Inc

SBFMW

View Detailed Chart

0.288USD

-0.012-4.10%

Close 04/23, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Sunshine Biopharma Inc

0.288

-0.012-4.10%

Company

Intraday

30m

Today

-4.10%

5 Days

-36.07%

1 Month

+17.43%

6 Months

+93.48%

Year to Date

+78.81%

1 Year

+299.58%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(2)

Buy(6)

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.003

Buy

RSI(14)

50.400

Neutral

STOCH(KDJ)(9,3,3)

29.595

Sell

ATR(14)

0.159

High Vlolatility

CCI(14)

-2.334

Neutral

Williams %R

64.633

Sell

TRIX(12,20)

2.670

Buy

StochRSI(14)

23.045

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

0.319

Sell

MA10

0.340

Sell

MA20

0.271

Buy

MA50

0.240

Buy

MA100

0.218

Buy

MA200

0.159

Buy

News

More news coming soon, stay tuned...

Company

Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.

Company codeSBFMW

CompanySunshine Biopharma Inc

CEODr. Steve N. Slilaty

Websitehttps://www.sunshinebiopharma.com/